CAS 99697-24-2: (3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]butanoic acid (non-preferred name)

24-Norursodeoxycholic acid

Applications Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),

Applications Labelled Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),

24-Norursodeoxycholic acid is a synthetic bile acid derivative, which is a modified form derived from natural bile acids. Its primary source is the chemical synthesis of ursodeoxycholic acid analogs. The mode of action involves modulating bile acid composition within the liver, thereby reducing cytotoxicity associated with bile acid accumulation. This modulation helps protect hepatocytes from damage, reducing liver inflammation and fibrosis. 24-Norursodeoxycholic acid is primarily used in research related to hepatic diseases, particularly in exploring its efficacy in chronic liver conditions such as primary biliary cholangitis and non-alcoholic fatty liver disease (NAFLD). By altering bile acid pathways, it provides insights into therapeutic approaches for liver damage mitigation. Its application extends to understanding cholestatic liver conditions, offering potential avenues for novel treatments by intervening in bile acid pathways and enhancing bile flow. As a chemical tool, it supports the investigation of liver disease mechanisms, making it invaluable in hepatology research contexts.

24-Norursodeoxycholic acid (nor-UDCA) is a Ursodeoxycholic Acid derivative. It has potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.